Serial Contrast-Enhanced Cardiac Magnetic Resonance Imaging Demonstrates Regression of Hyperenhancement Within the Coronary Artery Wall in Patients After Acute Myocardial Infarction

JACC: Cardiovascular Imaging

Volumn 2, Issue 5, 2009, Pages 580-588

  Ibrahim, Tareq ^a   Makowski, Markus R ^b   Jankauskas, Antanas ^b   Maintz, David ^d   Karch, Martin ^a   Schachoff, Sylvia ^b   Manning, Warren J ^c   Schömig, Albert ^a   Schwaiger, Markus ^b   Botnar, Rene M ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

acute myocardial infarction; cardiac magnetic resonance; coronary artery; late enhancement

Indexed keywords

C REACTIVE PROTEIN; GADOLINIUM PENTETATE;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTERY WALL; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY STENT; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE EDEMA; POSTOPERATIVE INFLAMMATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SIGNAL PROCESSING; THREE DIMENSIONAL IMAGING;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; GADOLINIUM DTPA; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 65549152315     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2008.12.029     Document Type: Article

References (32)

1. Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T., and Murray C.J. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367 (2006) 1747-1757
2. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
3. Falk E., Shah P.K., and Fuster V. Coronary plaque disruption. Circulation 92 (1995) 657-671
4. Virmani R., Burke A.P., Farb A., and Kolodgie F.D. Pathology of the vulnerable plaque. J Am Coll Cardiol 47 (2006) C13-C18
5. Schoenhagen P., Ziada K.M., Vince D.G., Nissen S.E., and Tuzcu E.M. Arterial remodeling and coronary artery disease: the concept of "dilated" versus "obstructive" coronary atherosclerosis. J Am Coll Cardiol 38 (2001) 297-306
6. Fayad Z.A., and Fuster V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ Res 89 (2001) 305-316
7. Fayad Z.A., Fuster V., Fallon J.T., et al. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation 102 (2000) 506-510
8. Botnar R.M., Stuber M., Kissinger K.V., Kim W.Y., Spuentrup E., and Manning W.J. Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging. Circulation 102 (2000) 2582-2587
9. Kim W.Y., Stuber M., Bornert P., Kissinger K.V., Manning W.J., and Botnar R.M. Three-dimensional black-blood cardiac magnetic resonance coronary vessel wall imaging detects positive arterial remodeling in patients with nonsignificant coronary artery disease. Circulation 106 (2002) 296-299
10. Yuan C., Kerwin W.S., Ferguson M.S., et al. Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. J Magn Reson Imaging 15 (2002) 62-67
11. Wasserman B.A., Smith W.I., Trout III H.H., Cannon III R.O., Balaban R.S., and Arai A.E. Carotid artery atherosclerosis: in vivo morphologic characterization with gadolinium-enhanced double-oblique MR imaging initial results. Radiology 223 (2002) 566-573
12. Kerwin W., Hooker A., Spilker M., et al. Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation 107 (2003) 851-856
13. Cai J., Hatsukami T.S., Ferguson M.S., et al. In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology. Circulation 112 (2005) 3437-3444
14. Maintz D., Ozgun M., Hoffmeier A., et al. Selective coronary artery plaque visualization and differentiation by contrast-enhanced inversion prepared MRI. Eur Heart J 27 (2006) 1732-1736
15. Yeon S.B., Sabir A., Clouse M., et al. Delayed-enhancement cardiovascular magnetic resonance coronary artery wall imaging: comparison with multislice computed tomography and quantitative coronary angiography. J Am Coll Cardiol 50 (2007) 441-447
16. Bley T.A., Wieben O., Uhl M., Thiel J., Schmidt D., and Langer M. High-resolution MRI in giant cell arteritis: imaging of the wall of the superficial temporal artery. AJR Am J Roentgenol 184 (2005) 283-287
17. Choe Y.H., Han B.K., Koh E.M., Kim D.K., Do Y.S., and Lee W.R. Takayasu's arteritis: assessment of disease activity with contrast-enhanced MR imaging. AJR Am J Roentgenol 175 (2000) 505-511
18. Spuentrup E., Bornert P., Botnar R.M., Groen J.P., Manning W.J., and Stuber M. Navigator-gated free-breathing three-dimensional balanced fast field echo (TrueFISP) coronary magnetic resonance angiography. Invest Radiol 37 (2002) 637-642
19. Stuber M., Botnar R.M., Danias P.G., et al. Contrast agent-enhanced, free-breathing, three-dimensional coronary magnetic resonance angiography. J Magn Reson Imaging 10 (1999) 790-799
20. Botnar R.M., Buecker A., Wiethoff A.J., et al. In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent. Circulation 110 (2004) 1463-1466
21. Etienne A., Botnar R.M., Van Muiswinkel A.M., Boesiger P., Manning W.J., and Stuber M. "Soap-bubble" visualization and quantitative analysis of 3D coronary magnetic resonance angiograms. Magn Reson Med 48 (2002) 658-666
22. Kim R.J., Wu E., Rafael A., et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343 (2000) 1445-1453
23. Mahrholdt H., Goedecke C., Wagner A., et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 109 (2004) 1250-1258
24. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
25. Liuzzo G., Biasucci L.M., Gallimore J.R., et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 331 (1994) 417-424
26. De Servi S., Mariani M., Mariani G., and Mazzone A. C-reactive protein increase in unstable coronary disease cause or effect?. J Am Coll Cardiol 46 (2005) 1496-1502
27. Garcia-Dorado D., Oliveras J., Gili J., et al. Analysis of myocardial oedema by magnetic resonance imaging early after coronary artery occlusion with or without reperfusion. Cardiovasc Res 27 (1993) 1462-1469
28. Kerwin W.S., O'Brien K.D., Ferguson M.S., Polissar N., Hatsukami T.S., and Yuan C. Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. Radiology 241 (2006) 459-468
29. Lipinski M.J., Amirbekian V., Frias J.C., et al. MRI to detect atherosclerosis with gadolinium-containing immunomicelles targeting the macrophage scavenger receptor. Magn Reson Med 56 (2006) 601-610
30. Nahrendorf M., Jaffer F.A., Kelly K.A., et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 114 (2006) 1504-1511
31. Ruehm S.G., Corot C., Vogt P., Kolb S., and Debatin J.F. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 103 (2001) 415-422
32. Spuentrup E., Ruebben A., Mahnken A., et al. Artifact-free coronary magnetic resonance angiography and coronary vessel wall imaging in the presence of a new, metallic, coronary magnetic resonance imaging stent. Circulation 111 (2005) 1019-1026